Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arlindo L Castelhano

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Leporin B: a novel hexokinase II gene inducing agent from an unidentified fungusChaowei Zhang, Liang Jin, Belinda Mondie, et al.
Biochemical Pharmacology|June 15, 2004
[3H]OSIP339391, a selective, novel, and high affinity antagonist radioligand for adenosine A2B receptorsMike Stewart, Arno G Steinig, Chienling Ma, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Potent and selective [2-imidazol-1-yl-2-(6-alkoxy-naphthalen-2-yl)-1-methyl-ethyl]-dimethyl-amines as retinoic acid metabolic blocking agents (RAMBAs)Mark J Mulvihill, Julie L C Kan, Patricia Beck, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Glucokinase-activating ureasArlindo L Castelhano, Hanqing Dong, Matthew C T Fyfe, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2006
3-[6-(2-Dimethylamino-1-imidazol-1-yl-butyl)-naphthalen-2-yloxy]-2,2-dimethyl-propionic acid as a highly potent and selective retinoic acid metabolic blocking agentMark J Mulvihill, Julie L C Kan, Andrew Cooke, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Discovery of VU2957 (Valiglurax): An mGlu<sub>4</sub> Positive Allosteric Modulator Evaluated as a Preclinical Candidate for the Treatment of Parkinson's DiseaseJoseph D Panarese, Darren W Engers, Yong-Jin Wu, et al.
Cancer Research|January 21, 2006
OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft modelsAndrew J Garton, Andrew P A Crew, Maryland Franklin, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Leporin B: a novel hexokinase II gene inducing agent from an unidentified fungusChaowei Zhang, Liang Jin, Belinda Mondie, et al.
Biochemical Pharmacology|June 15, 2004
[3H]OSIP339391, a selective, novel, and high affinity antagonist radioligand for adenosine A2B receptorsMike Stewart, Arno G Steinig, Chienling Ma, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Potent and selective [2-imidazol-1-yl-2-(6-alkoxy-naphthalen-2-yl)-1-methyl-ethyl]-dimethyl-amines as retinoic acid metabolic blocking agents (RAMBAs)Mark J Mulvihill, Julie L C Kan, Patricia Beck, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2005
Glucokinase-activating ureasArlindo L Castelhano, Hanqing Dong, Matthew C T Fyfe, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2006
3-[6-(2-Dimethylamino-1-imidazol-1-yl-butyl)-naphthalen-2-yloxy]-2,2-dimethyl-propionic acid as a highly potent and selective retinoic acid metabolic blocking agentMark J Mulvihill, Julie L C Kan, Andrew Cooke, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Discovery of VU2957 (Valiglurax): An mGlu<sub>4</sub> Positive Allosteric Modulator Evaluated as a Preclinical Candidate for the Treatment of Parkinson's DiseaseJoseph D Panarese, Darren W Engers, Yong-Jin Wu, et al.
Cancer Research|January 21, 2006
OSI-930: a novel selective inhibitor of Kit and kinase insert domain receptor tyrosine kinases with antitumor activity in mouse xenograft modelsAndrew J Garton, Andrew P A Crew, Maryland Franklin, et al.
Pageof 1